Global biostimulants market is projected to register a healthy CAGR of 12.5% in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Market Segmentation
By Active Ingredients (Acid Based, Extract Based, Protein Hydrolysates, Microbial Amendments, Chitin, Chitosan, B-Vitamins, Others), Crop Type (Fruits & Vegetables, Cereals & Grains, Oilseeds & Pulses, Turf & Ornamentals, Other Crops), Application Method (Foliar Treatment, Soil Treatment, Seed Treatment), Form (Liquid, Dry), End User (Farmers, Related Industries, Research Institutes), Origin (Natural Biostimulants, Synthetic Biostimulants), Distribution Channel (Direct, Indirect), Country (U.S., Canada and Mexico, Germany, U.K., France, Italy, Switzerland, Spain, Russia, Belgium, Netherlands, Turkey and Rest of Europe, China, Japan, South Korea, India, Singapore, Australia, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific, U.A.E., Saudi Arabia, Egypt, South Africa, Israel and Rest of Middle East and Africa) Market Trends and forecast to 2027.
Some of the major factors contributing to the growth of global biostimulants market:
- Rising organic agriculture sector
- High disposable income
Key Market Players
The key market players for global biostimulants market are listed below:
- Eastman Chemical Company
- OMEX
- LALLEMAND Inc.
- Agrinos
- Brandt Consolidated, Inc.
- FMC Corporation
- Valagro SpA
- Biolchim SPA
- Isagro
- Italpollina S.p.A.
- ADAMA Ltd
- KOPPERT BIOLOGICAL SYSTEMS
- Haifa Group
- Novozymes
- ACADIAN SEAPLANTS LIMITED
- ATLANTICA AGRICOLA
- Biostadt India Limited
- Trade Corporation International
- AGROENZYMAS
- MICROMIX
- Syngenta
- Bayer AG
- UPL
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 OBJECTIVES OF THE STUDY
- 1.2 MARKET DEFINITION
- 1.3 OVERVIEW OF GLOBAL BIOSTIMULANTS MARKET
- 1.4 CURRENCY AND PRICING
- 1.5 LIMITATIONS
- 1.6 MARKETS COVERED
2 MARKET SEGMENTATION
- 2.1 MARKETS COVERED
- 2.2 GEOGRAPHICAL SCOPE
- 2.3 YEARS CONSIDERED FOR THE STUDY
- 2.4 DBMR TRIPOD DATA VALIDATION MODEL
- 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
- 2.6 DBMR MARKET POSITION GRID
- 2.7 MULTIVARIATE MODELING
- 2.8 PRODUCT TIMELINE CURVE
- 2.9 SECONDARY SOURCES
- 2.10 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATORY SCENARIO
6 MARKET OVERVIEW
- 6.1 DRIVERS
- 6.1.1 INCREASIG NEED FOR SUSTAINABLE AGRICULTURE
- 6.1.2 UPSURGE IN THE DEMAND OF SEAWEEDS AS RAW MATERIAL
- 6.1.3 HIGH AGRICULTURAL PRODUCTION WORLDWIDE
- 6.1.4 HIGH DEMAND FOR ORGANIC FARMING
- 6.2 RESTRAINT
- 6.2.1 QUALITY ISSUE IN MANUFACTURING BIOSTIMULANTS
- 6.3 OPPORTUNITIES
- 6.3.1 RISING AWARENESS ABOUT BIOSTIMULANTS
- 6.3.2 STRATEGIC INITIATIVES BY ORGANIZATIONS
- 6.4 CHALLENGES
- 6.4.1 HIGH DEMAND OF SUBSTITUTE PRODUCTS
- 6.4.2 UNCERTAINTY IN BIOSTIMULANT REGULATION WORLDWIDE
7 GLOBAL BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENTS
- 7.1 OVERVIEW
- 7.2 ACID BASED
- 7.2.1 AMINO ACID
- 7.2.2 HUMIC AND FULVIC ACIDS
- 7.3 EXTRACT BASED
- 7.3.1 SEAWEED EXTRACTS
- 7.3.2 PLANT EXTRACT
- 7.3.3 FUNGAL EXTRACT
- 7.4 PROTEIN HYDROLYSATES
- 7.5 MICROBIAL AMENDMENTS
- 7.6 CHITIN
- 7.7 CHITOSAN
- 7.8 B-VITAMINS
- 7.9 OTHERS
8 GLOBAL BIOSTIMULANTS MARKET, BY CROP TYPE
- 8.1 OVERVIEW
- 8.2 FRUITS & VEGETABLES
- 8.3 CEREALS & GRAINS
- 8.4 OILSEEDS & PULSES
- 8.5 TURF & ORNAMENTALS
- 8.6 OTHER CROPS
9 GLOBAL BIOSTIMULANTS MARKET, BY APPLICATION METHOD
- 9.1 OVERVIEW
- 9.2 FOLIAR TREATMENT
- 9.3 SOIL TREATMENT
- 9.4 SEED TREATMENT
10 GLOBAL BIOSTIMULANTS MARKET, BY FORM
- 10.1 OVERVIEW
- 10.2 LIQUID
- 10.2.1 SOLUBLE LIQUID CONCENTRATE
- 10.2.2 EMULSIFIABLE CONCENTRATE
- 10.2.3 SUSPENSION CONCENTRATE
- 10.3 DRY
- 10.3.1 WETTABLE POWDER
- 10.3.2 DRY GRANULES
- 10.3.3 WATER DISPERSIBLE
11 GLOBAL BIOSTIMULANTS MARKET, BY END USER
- 11.1 OVERVIEW
- 11.2 FARMERS
- 11.3 RELATED INDUSTRIES
- 11.4 RESEARCH INSTITUTES
12 GLOBAL BIOSTIMULANTS MARKET, BY ORIGIN
- 12.1 OVERVIEW
- 12.2 NATURAL BIOSTIMULANTS
- 12.3 SYNTHETIC BIOSTIMULANTS
13 GLOBAL BIOSTIMULANTS MARKET, BY DISTRIBUTION CHANNEL
- 13.1 OVERVIEW
- 13.2 DIRECT
- 13.3 INDIRECT
14 GLOBAL BIOSTIMULANTS MARKET, BY GEOGRAPHY
- 14.1 OVERVIEW
- 14.2 EUROPE
- 14.2.1 SPAIN
- 14.2.2 ITALY
- 14.2.3 U.K.
- 14.2.4 FRANCE
- 14.2.5 GERMANY
- 14.2.6 NETHERLANDS
- 14.2.7 SWITZERLAND
- 14.2.8 RUSSIA
- 14.2.9 BELGIUM
- 14.2.10 TURKEY
- 14.2.11 REST OF EUROPE
- 14.3 NORTH AMERICA
- 14.3.1 U.S.
- 14.3.2 CANADA
- 14.3.3 MEXICO
- 14.4 ASIA-PACIFIC
- 14.4.1 INDIA
- 14.4.2 CHINA
- 14.4.3 AUSTRALIA
- 14.4.4 JAPAN
- 14.4.5 SOUTH KOREA
- 14.4.6 SINGAPORE
- 14.4.7 MALAYSIA
- 14.4.8 THAILAND
- 14.4.9 INDONESIA
- 14.4.10 PHILIPPINES
- 14.4.11 REST OF ASIA-PACIFIC
- 14.5 SOUTH AMERICA
- 14.5.1 BRAZIL
- 14.5.2 ARGENTINA
- 14.5.3 REST OF SOUTH AMERICA
- 14.6 MIDDLE EAST AND AFRICA
- 14.6.1 SOUTH AFRICA
- 14.6.2 EGYPT
- 14.6.3 SAUDI ARBIA
- 14.6.4 ISRAEL
- 14.6.5 UNITED ARAB EMIRATES
- 14.6.6 REST OF MIDDLE EAST AND AFRICA
15 GLOBAL BIOSTIMULANTS MARKET, COMPANY LANDSCAPE
- 15.1 COMPANY SHARE ANALYSIS: GLOBAL
- 15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
- 15.3 COMPANY SHARE ANALYSIS: EUROPE
- 15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16 COMPANY PROFILE
- 16.1 ADAMA LTD.
- 16.1.1 COMPANY SNAPSHOT
- 16.1.2 REVENUE ANALYSIS
- 16.1.3 COMPANY SHARE ANALYSIS
- 16.1.4 PRODUCT PORTFOLIO
- 16.1.5 RECENT DEVELOPMENT
- 16.2 SYNGENTA
- 16.2.1 COMPANY SNAPSHOT
- 16.2.2 REVENUE ANALYSIS
- 16.2.3 COMPANY SHARE ANALYSIS
- 16.2.4 PRODUCT PORTFOLIO
- 16.2.5 RECENT DEVELOPMENT
- 16.3 NOVOZYMES
- 16.3.1 COMPANY SNAPSHOT
- 16.3.2 REVENUE ANALYSIS
- 16.3.3 COMPANY SHARE ANALYSIS
- 16.3.4 PRODUCT PORTFOLIO
- 16.3.5 RECENT DEVELOPMENT
- 16.4 FMC CORPORATION
- 16.4.1 COMPANY SNAPSHOT
- 16.4.2 REVENUE ANALYSIS
- 16.4.3 COMPANY SHARE ANALYSIS
- 16.4.4 PRODUCT PORTFOLIO
- 16.4.5 RECENT DEVELOPMENT
- 16.5 EASTMAN CHEMICAL COMPANY
- 16.5.1 COMPANY SNAPSHOT
- 16.5.2 REVENUE ANALYSIS
- 16.5.3 COMPANY SHARE ANALYSIS
- 16.5.4 PRODUCT PORTFOLIO
- 16.5.5 RECENT DEVELOPMENTS
- 16.6 OMEX
- 16.6.1 COMPANY SNAPSHOT
- 16.6.2 PRODUCT PORTFOLIO
- 16.6.3 RECENT DEVELOPMENT
- 16.7 ACADIAN SEAPLANTS LIMITED
- 16.7.1 COMPANY SNAPSHOT
- 16.7.2 PRODUCT PORTFOLIO
- 16.7.3 RECENT DEVELOPMENT
- 16.8 AGRINOS
- 16.8.1 COMPANY SNAPSHOT
- 16.8.2 PRODUCT PORTFOLIO
- 16.8.3 RECENT DEVELOPMENT
- 16.9 AGROENZYMAS
- 16.9.1 COMPANY SNAPSHOT
- 16.9.2 PRODUCT PORTFOLIO
- 16.9.3 RECENT DEVELOPMENT
- 16.10 ATLANTICA AGRICOLA
- 16.10.1 COMPANY SNAPSHOT
- 16.10.2 PRODUCT PORTFOLIO
- 16.10.3 RECENT DEVELOPMENTS
- 16.11 BAYER AG
- 16.11.1 COMPANY SNAPSHOT
- 16.11.2 REVENUE ANALYSIS
- 16.11.3 PRODUCT PORTFOLIO
- 16.11.4 RECENT DEVELOPMENTS
- 16.12 BIOLCHIM SPA
- 16.12.1 COMPANY SNAPSHOT
- 16.12.2 PRODUCT PORTFOLIO
- 16.12.3 RECENT DEVELOPMENTS
- 16.13 BIOSTADT INDIA LIMITED
- 16.13.1 COMPANY SNAPSHOT
- 16.13.2 PRODUCT PORTFOLIO
- 16.13.3 RECENT DEVELOPMENT
- 16.14 BRANDT CONSOLIDATED, INC.
- 16.14.1 COMPANY SNAPSHOT
- 16.14.2 PRODUCT PORTFOLIO
- 16.14.3 RECENT DEVELOPMENT
- 16.15 HAIFA GROUP
- 16.15.1 COMPANY SNAPSHOT
- 16.15.2 PRODUCT PORTFOLIO
- 16.15.3 RECENT DEVELOPMENT
- 16.16 ISAGRO
- 16.16.1 COMPANY SNAPSHOT
- 16.16.2 REVENUE ANALYSIS
- 16.16.3 PRODUCT PORTFOLIO
- 16.16.4 RECENT DEVELOPMENT
- 16.17 ITALPOLLINA S.P.A.
- 16.17.1 COMPANY SNAPSHOT
- 16.17.2 PRODUCT PORTFOLIO
- 16.17.3 RECENT DEVELOPMENTS
- 16.18 KOPPERT BIOLOGICAL SYSTEMS
- 16.18.1 COMPANY SNAPSHOT
- 16.18.2 PRODUCT PORTFOLIO
- 16.18.3 RECENT DEVELOPMENT
- 16.19 LALLEMAND INC.
- 16.19.1 COMPANY SNAPSHOT
- 16.19.2 PRODUCT PORTFOLIO
- 16.19.3 RECENT DEVELOPMENTS
- 16.20 MICROMIX
- 16.20.1 COMPANY SNAPSHOT
- 16.20.2 PRODUCT PORTFOLIO
- 16.20.3 RECENT DEVELOPMENT
- 16.21 TRADE CORPORATION INTERNATIONAL
- 16.21.1 COMPANY SNAPSHOT
- 16.21.2 PRODUCT PORTFOLIO
- 16.21.3 RECENT DEVELOPMENT
- 16.22 UPL
- 16.22.1 COMPANY SNAPSHOT
- 16.22.2 REVENUE ANALYSIS
- 16.22.3 SOLUTION PORTFOLIO
- 16.22.4 RECENT DEVELOPMENT
- 16.23 VALAGRO SPA
- 16.23.1 COMPANY SNAPSHOT
- 16.23.2 PRODUCT PORTFOLIO
- 16.23.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS